Bio-Techne Corporation ( TECH) Q3 2026 Earnings Call May 6, 2026 9:00 AM EDT Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter and Fiscal Year 2026. [Operator ...

Mission Bio, the single-cell multi-omics leader, today released data showing that its Targeted Single-Cell DNA+RNA Assay ...

Within hours of the first headlines about a hantavirus outbreak linked to the expedition cruise ship MV Hondius, my DMs ...

Scientists may have uncovered a surprising secret behind why life exists at all. A new study suggests that the Universe’s ...

Ted Morrissey, author of 'Aspiring Child A Biography of Mary W Shelley in Sonnets' comes to the NPR Illinois studios. He ...

Spa-Francorchamps was where Archie Scott Brown’s story ended. A British sports-car driver of the 1950s, he won famous races, ...

Company to Host Conference Call Today, May 7th, at 4:30pm ETBOCA RATON, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company ...

Stacker used information from IMDb to rank the worst movies of the '90s. The rankings are based on user reviews from the ...

More than 300 members of the Pacific Northwest tech scene packed the Showbox SoDo to honor the year's top startups, founders, ...

Trump thought Iran would fold. Now his war is dragging on, Congress is struggling and even the pope is in his sights.

The findings, which led to a provisional patent filing, suggest Converge Bio improved cetuximab bindings to the receptor, achieving 2x higher affinity using a single AI prompt, strengthening its ...